Medical care from childhood to adulthood in type 1 and type 2 diabetes

G Costi1, S Ten, N K Maclaren

  • 1Weill Medical College, Cornell University, New York, NY 10021, USA. costi@lycos.com

Insights

Identifying genetic predispositions for diabetes, like Maturity-Onset Diabetes of the Young (MODY) and Wolfram syndrome, allows for early diagnosis and tailored preventive interventions, reducing long-term complications.

Area of Science:

  • Endocrinology
  • Medical Genetics
  • Diabetes Research

Background:

  • Diabetes mellitus presents diverse complications, necessitating early risk identification.
  • Genetic factors play a crucial role in diabetes development, particularly in family members of affected individuals.
  • Accurate etiological diagnosis is vital for effective diabetes management and treatment.

Purpose of the Study:

  • To highlight the importance of genetic diagnosis in identifying specific diabetes subtypes.
  • To emphasize the role of genetic analysis in early detection and preventive strategies for diabetes.
  • To underscore the benefits of integrated family care in managing diabetes and its complications.

Main Methods:

  • Review of genetic factors associated with Type 1 and Type 2 diabetes.
  • Analysis of diagnostic criteria for monogenic diabetes forms like MODY and Wolfram syndrome.
  • Evaluation of genetic testing and family history in differential diagnosis of diabetes.

Main Results:

  • Genetic discoveries enhance understanding of diabetes pathogenesis and diagnosis of monogenic forms.
  • Identification of high-risk individuals through genetic screening enables timely preventive interventions.
  • Specific genetic conditions like MODY and mitochondrial mutations require distinct diagnostic approaches.

Conclusions:

  • Genetic insights are revolutionizing diabetes diagnosis, enabling precise etiological identification.
  • Early genetic diagnosis facilitates personalized preventive strategies, mitigating diabetes-related complications.
  • Comprehensive family follow-up in specialized centers optimizes diabetes management and intervention effectiveness.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...